BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16883158)

  • 1. Surgifoam and mitoxantrone in the glioblastoma multiforme postresection cavity: the first step of locoregional chemotherapy through an ad hoc-placed catheter: technical note.
    Ferroli P; Broggi M; Franzini A; Maccagnano E; Lamperti M; Boiardi A; Broggi G
    Neurosurgery; 2006 Aug; 59(2):E433-4; discussion E433-4. PubMed ID: 16883158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.
    Telfeian AE; Philips MF; Crino PB; Judy KD
    J Exp Clin Cancer Res; 2001 Mar; 20(1):5-10. PubMed ID: 11370829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M; Takeda N; Tanaka R
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
    Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
    Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
    Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma multiforme in pregnancy.
    Mackenzie AP; Levine G; Garry D; Figueroa R
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):81-3. PubMed ID: 15804792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma by placing a temporary catheter via the subclavian route.
    Liang HL; Huang JS; Lin YH; Lai KH; Yang CF; Pan HB
    Acta Radiol; 2007 Sep; 48(7):734-40. PubMed ID: 17729003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.
    Boiardi A; Bartolomei M; Silvani A; Eoli M; Salmaggi A; Lamperti E; Milanesi I; Botturi A; Rocca P; Bodei L; Broggi G; Paganelli G
    J Neurooncol; 2005 Apr; 72(2):125-31. PubMed ID: 15925992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.
    Aiken AH; Chang SM; Larson D; Butowski N; Cha S
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1340-6. PubMed ID: 18538496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of glioblastoma multiforme today].
    Neumann J
    Nervenarzt; 1983 Apr; 54(4):191-3. PubMed ID: 6304545
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
    Chang SM; Butowski NA; Sneed PK; Garner IV
    Neurosurg Focus; 2006 Apr; 20(4):E4. PubMed ID: 16709035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma.
    Boiardi A; Eoli M; Salmaggi A; Lamperti E; Botturi A; Broggi G; Bissola L; Finocchiaro G; Silvani A
    J Neurooncol; 2005 Nov; 75(2):215-20. PubMed ID: 16283445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.